Current clinical diagnosis in Creutzfeldt-Jakob disease: identification of uncommon variants
- PMID: 10976638
Current clinical diagnosis in Creutzfeldt-Jakob disease: identification of uncommon variants
Abstract
According to the recently established molecular basis for phenotypic heterogeneity of sporadic Creutzfeldt-Jakob disease (CJD), six different phenotypes are characterized by the size of the protease-resistant fragment of the pathological prion protein (types 1 and 2) and homozygosity or heterozygosity for methionine or valine at codon 129 of the prion protein gene (designated by MM1, MM2, MV1, MV2, W1, and W2). In the present investigation, we analyzed the value of commonly used clinical tests (electroencephalogram [EEG], detection of 14-3-3 protein in cerebrospinal fluid [CSF], and hyperintensity of the basal ganglia in magnetic resonance imaging) for the clinical diagnosis in each CJD phenotype. The detection of periodic sharp and slow wave complexes in the EEG is reliable in the clinical diagnosis of MM1 and MV1 patients only. The CSF analysis for 14-3-3 protein showed high sensitivity in all analyzed subgroups with the exception of MV2 patients. Valine-homozygous patients had a negative EEG, but most had detectable levels of neuronal proteins in the CSF. The sensitivity of the magnetic resonance imaging was 70%, irrespective of the subgroup, but was particularly reliable in the clinical diagnosis of MV2 patients. The widening spectrum of diagnostic techniques in CJD is not only useful in the increased accuracy of the clinical diagnosis but should also lead to the identification of more atypical cases of sporadic CJD.
Similar articles
-
Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease.Brain. 2006 Sep;129(Pt 9):2278-87. doi: 10.1093/brain/awl159. Epub 2006 Jul 1. Brain. 2006. PMID: 16816392
-
Characteristics of established and proposed sporadic Creutzfeldt-Jakob disease variants.Arch Neurol. 2009 Feb;66(2):208-15. doi: 10.1001/archneurol.2008.533. Arch Neurol. 2009. PMID: 19204157
-
Autopsy-proven Creutzfeldt-Jakob disease in a patient with a negative 14-3-3 assay and nonspecific EEG and MRI.Neurol Sci. 2004 Feb;24(6):411-3. doi: 10.1007/s10072-003-0198-8. Neurol Sci. 2004. PMID: 14767688
-
EEG in Creutzfeldt-Jakob disease.Clin Neurophysiol. 2006 May;117(5):935-51. doi: 10.1016/j.clinph.2005.12.007. Epub 2006 Jan 25. Clin Neurophysiol. 2006. PMID: 16442343 Review.
-
Diffusion-weighted MRI in Creutzfeldt-Jakob disease: a better diagnostic marker than CSF protein 14-3-3?J Neuroimaging. 2003 Apr;13(2):147-51. J Neuroimaging. 2003. PMID: 12722497 Review.
Cited by
-
Focal sharp waves are a specific early-stage marker of the MM2-cortical form of sporadic Creutzfeldt-Jakob disease.Prion. 2020 Dec;14(1):207-213. doi: 10.1080/19336896.2020.1803516. Prion. 2020. PMID: 32787547 Free PMC article.
-
14-3-3s are potential biomarkers for HIV-related neurodegeneration.J Neurovirol. 2012 Oct;18(5):341-53. doi: 10.1007/s13365-012-0121-2. Epub 2012 Jul 19. J Neurovirol. 2012. PMID: 22811265 Free PMC article. Review.
-
Case 8: absentminded and "walking like a drunk".MedGenMed. 2005 Feb 3;7(1):64. MedGenMed. 2005. PMID: 16369369 Free PMC article. No abstract available.
-
Preventive or promotive effects of PRNP polymorphic heterozygosity on the onset of prion disease.Heliyon. 2023 Feb 24;9(3):e13974. doi: 10.1016/j.heliyon.2023.e13974. eCollection 2023 Mar. Heliyon. 2023. PMID: 36915552 Free PMC article.
-
Radiological assessment of Creutzfeldt-Jakob disease.Eur Radiol. 2007 May;17(5):1200-11. doi: 10.1007/s00330-006-0456-2. Epub 2006 Nov 9. Eur Radiol. 2007. PMID: 17093966 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical